The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Immune-Mediated Inflammatory Diseases Treatment Market Research Report 2025

Global Immune-Mediated Inflammatory Diseases Treatment Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1889709

No of Pages : 71

Synopsis
Immune-Mediated Inflammatory Diseases Treatment is any of a group of conditions or diseases that lack a definitive etiology, but which are characterized by common inflammatory pathways leading to inflammation, and which may result from, or be triggered by, a dysregulation of the normal immune response.
The global Immune-Mediated Inflammatory Diseases Treatment market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Immune-Mediated Inflammatory Diseases Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Immune-Mediated Inflammatory Diseases Treatment.
Report Scope
The Immune-Mediated Inflammatory Diseases Treatment market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Immune-Mediated Inflammatory Diseases Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Immune-Mediated Inflammatory Diseases Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
GlaxoSmithKline
Eli Lilly
AstraZeneca
Bristol-Myers
Sanofi
Roche
Enlivex Therapeutics
Immune Pharmaceuticals
Tanabe Pharma
Segment by Type
Targeted biologic therapies
Novel therapies
Segment by Application
Hospitals
Pharmacy Store
Online Pharmacy Stroe
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Immune-Mediated Inflammatory Diseases Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Immune-Mediated Inflammatory Diseases Treatment Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Targeted biologic therapies
1.2.3 Novel therapies
1.3 Market by Application
1.3.1 Global Immune-Mediated Inflammatory Diseases Treatment Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Pharmacy Store
1.3.4 Online Pharmacy Stroe
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Immune-Mediated Inflammatory Diseases Treatment Market Perspective (2019-2030)
2.2 Immune-Mediated Inflammatory Diseases Treatment Growth Trends by Region
2.2.1 Global Immune-Mediated Inflammatory Diseases Treatment Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Immune-Mediated Inflammatory Diseases Treatment Historic Market Size by Region (2019-2024)
2.2.3 Immune-Mediated Inflammatory Diseases Treatment Forecasted Market Size by Region (2025-2030)
2.3 Immune-Mediated Inflammatory Diseases Treatment Market Dynamics
2.3.1 Immune-Mediated Inflammatory Diseases Treatment Industry Trends
2.3.2 Immune-Mediated Inflammatory Diseases Treatment Market Drivers
2.3.3 Immune-Mediated Inflammatory Diseases Treatment Market Challenges
2.3.4 Immune-Mediated Inflammatory Diseases Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Immune-Mediated Inflammatory Diseases Treatment Players by Revenue
3.1.1 Global Top Immune-Mediated Inflammatory Diseases Treatment Players by Revenue (2019-2024)
3.1.2 Global Immune-Mediated Inflammatory Diseases Treatment Revenue Market Share by Players (2019-2024)
3.2 Global Immune-Mediated Inflammatory Diseases Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Immune-Mediated Inflammatory Diseases Treatment Revenue
3.4 Global Immune-Mediated Inflammatory Diseases Treatment Market Concentration Ratio
3.4.1 Global Immune-Mediated Inflammatory Diseases Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Immune-Mediated Inflammatory Diseases Treatment Revenue in 2023
3.5 Immune-Mediated Inflammatory Diseases Treatment Key Players Head office and Area Served
3.6 Key Players Immune-Mediated Inflammatory Diseases Treatment Product Solution and Service
3.7 Date of Enter into Immune-Mediated Inflammatory Diseases Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Immune-Mediated Inflammatory Diseases Treatment Breakdown Data by Type
4.1 Global Immune-Mediated Inflammatory Diseases Treatment Historic Market Size by Type (2019-2024)
4.2 Global Immune-Mediated Inflammatory Diseases Treatment Forecasted Market Size by Type (2025-2030)
5 Immune-Mediated Inflammatory Diseases Treatment Breakdown Data by Application
5.1 Global Immune-Mediated Inflammatory Diseases Treatment Historic Market Size by Application (2019-2024)
5.2 Global Immune-Mediated Inflammatory Diseases Treatment Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Immune-Mediated Inflammatory Diseases Treatment Market Size (2019-2030)
6.2 North America Immune-Mediated Inflammatory Diseases Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Immune-Mediated Inflammatory Diseases Treatment Market Size by Country (2019-2024)
6.4 North America Immune-Mediated Inflammatory Diseases Treatment Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Immune-Mediated Inflammatory Diseases Treatment Market Size (2019-2030)
7.2 Europe Immune-Mediated Inflammatory Diseases Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Immune-Mediated Inflammatory Diseases Treatment Market Size by Country (2019-2024)
7.4 Europe Immune-Mediated Inflammatory Diseases Treatment Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Immune-Mediated Inflammatory Diseases Treatment Market Size (2019-2030)
8.2 Asia-Pacific Immune-Mediated Inflammatory Diseases Treatment Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Immune-Mediated Inflammatory Diseases Treatment Market Size by Region (2019-2024)
8.4 Asia-Pacific Immune-Mediated Inflammatory Diseases Treatment Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Immune-Mediated Inflammatory Diseases Treatment Market Size (2019-2030)
9.2 Latin America Immune-Mediated Inflammatory Diseases Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Immune-Mediated Inflammatory Diseases Treatment Market Size by Country (2019-2024)
9.4 Latin America Immune-Mediated Inflammatory Diseases Treatment Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Immune-Mediated Inflammatory Diseases Treatment Market Size (2019-2030)
10.2 Middle East & Africa Immune-Mediated Inflammatory Diseases Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Immune-Mediated Inflammatory Diseases Treatment Market Size by Country (2019-2024)
10.4 Middle East & Africa Immune-Mediated Inflammatory Diseases Treatment Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 GlaxoSmithKline
11.1.1 GlaxoSmithKline Company Detail
11.1.2 GlaxoSmithKline Business Overview
11.1.3 GlaxoSmithKline Immune-Mediated Inflammatory Diseases Treatment Introduction
11.1.4 GlaxoSmithKline Revenue in Immune-Mediated Inflammatory Diseases Treatment Business (2019-2024)
11.1.5 GlaxoSmithKline Recent Development
11.2 Eli Lilly
11.2.1 Eli Lilly Company Detail
11.2.2 Eli Lilly Business Overview
11.2.3 Eli Lilly Immune-Mediated Inflammatory Diseases Treatment Introduction
11.2.4 Eli Lilly Revenue in Immune-Mediated Inflammatory Diseases Treatment Business (2019-2024)
11.2.5 Eli Lilly Recent Development
11.3 AstraZeneca
11.3.1 AstraZeneca Company Detail
11.3.2 AstraZeneca Business Overview
11.3.3 AstraZeneca Immune-Mediated Inflammatory Diseases Treatment Introduction
11.3.4 AstraZeneca Revenue in Immune-Mediated Inflammatory Diseases Treatment Business (2019-2024)
11.3.5 AstraZeneca Recent Development
11.4 Bristol-Myers
11.4.1 Bristol-Myers Company Detail
11.4.2 Bristol-Myers Business Overview
11.4.3 Bristol-Myers Immune-Mediated Inflammatory Diseases Treatment Introduction
11.4.4 Bristol-Myers Revenue in Immune-Mediated Inflammatory Diseases Treatment Business (2019-2024)
11.4.5 Bristol-Myers Recent Development
11.5 Sanofi
11.5.1 Sanofi Company Detail
11.5.2 Sanofi Business Overview
11.5.3 Sanofi Immune-Mediated Inflammatory Diseases Treatment Introduction
11.5.4 Sanofi Revenue in Immune-Mediated Inflammatory Diseases Treatment Business (2019-2024)
11.5.5 Sanofi Recent Development
11.6 Roche
11.6.1 Roche Company Detail
11.6.2 Roche Business Overview
11.6.3 Roche Immune-Mediated Inflammatory Diseases Treatment Introduction
11.6.4 Roche Revenue in Immune-Mediated Inflammatory Diseases Treatment Business (2019-2024)
11.6.5 Roche Recent Development
11.7 Enlivex Therapeutics
11.7.1 Enlivex Therapeutics Company Detail
11.7.2 Enlivex Therapeutics Business Overview
11.7.3 Enlivex Therapeutics Immune-Mediated Inflammatory Diseases Treatment Introduction
11.7.4 Enlivex Therapeutics Revenue in Immune-Mediated Inflammatory Diseases Treatment Business (2019-2024)
11.7.5 Enlivex Therapeutics Recent Development
11.8 Immune Pharmaceuticals
11.8.1 Immune Pharmaceuticals Company Detail
11.8.2 Immune Pharmaceuticals Business Overview
11.8.3 Immune Pharmaceuticals Immune-Mediated Inflammatory Diseases Treatment Introduction
11.8.4 Immune Pharmaceuticals Revenue in Immune-Mediated Inflammatory Diseases Treatment Business (2019-2024)
11.8.5 Immune Pharmaceuticals Recent Development
11.9 Tanabe Pharma
11.9.1 Tanabe Pharma Company Detail
11.9.2 Tanabe Pharma Business Overview
11.9.3 Tanabe Pharma Immune-Mediated Inflammatory Diseases Treatment Introduction
11.9.4 Tanabe Pharma Revenue in Immune-Mediated Inflammatory Diseases Treatment Business (2019-2024)
11.9.5 Tanabe Pharma Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Published By : QY Research

Why ‘The Market Reports’